LGND: Ligand Pharmaceuticals Incorporated Stock

by  •  • Comments Off on LGND: Ligand Pharmaceuticals Incorporated Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2,014.50
Enterprise Value ($M) 1,758.33
Book Value ($M) 830.44
Book Value / Share 43.13
Price / Book 2.43
NCAV ($M) 220.22
NCAV / Share 11.44
Price / NCAV 9.15

Profitability (mra)
Return on Invested Capital (ROIC) -0.00
Return on Assets (ROA) -0.00
Return on Equity (ROE) -0.00

Liquidity (mrq)
Quick Ratio 8.55
Current Ratio 8.93

Balance Sheet (mrq) ($M)
Current Assets 331.56
Assets 941.77
Liabilities 111.33
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 167.13
Operating Income 23.02
Net Income -4.03
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 97.05
Cash from Investing -143.66
Cash from Financing 97.14

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Janus Henderson Group Plc 5.40 0.59
02-05 13G/A BlackRock, Inc. 15.60 -0.55
11-08 13G/A Goldman Sachs Group Inc 0.30 -95.57
11-01 13G/A Macquarie Group Ltd 4.86 -10.13

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ________________________________________________________________________________________ ☒ Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 29,812 87,447 34.09
2025-04-16 21,727 60,500 35.91
2025-04-15 10,592 41,172 25.73
2025-04-14 29,256 86,404 33.86

(click for more detail)

Similar Companies
KOD – Kodiak Sciences Inc. KROS – Keros Therapeutics, Inc.
KYMR – Kymera Therapeutics, Inc. LNTH – Lantheus Holdings, Inc.
LRMR – Larimar Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io